Cargando…

Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?

Detalles Bibliográficos
Autores principales:	Park, Suhyun, Park, Sang Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474489/ https://www.ncbi.nlm.nih.gov/pubmed/36104208 http://dx.doi.org/10.5009/gnl220364

Ejemplares similares

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
por: Park, Jihye
Publicado: (2023)

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
por: Park, Sang Hyoung
Publicado: (2022)

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries
por: Aniwan, Satimai, et al.
Publicado: (2022)

Addressing Sexual Dysfunction in Patients with Inflammatory Bowel Disease—We Can Do Better
por: Clarke, Kofi
Publicado: (2020)

Do We Have the Spark?
por: Rupel, Valentina Prevolnik, et al.
Publicado: (2022)

Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?
por: Cha, Jae Myung
Publicado: (2019)

The Asian Nuclear Medicine Board (ANMB); Why Do We Need It?
por: Durr-e-Sabih,
Publicado: (2013)

Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
Publicado: (2018)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Artificial intelligence in inflammatory bowel disease: current status and opportunities
por: Li, Ji, et al.
Publicado: (2020)

Do We Have Real Poverty in the United States of America?
por: Braveman, Paula
Publicado: (2007)

Asthma and COVID-19: do we finally have answers?
por: Eger, Katrien, et al.
Publicado: (2021)

We thrive not when we’ve done it all, but when we still have more to do (S. Lewis)
por: Hefti, F, et al.
Publicado: (2022)

Chronic myeloid leukemia in children, do we have all the answers?
por: Bansal, Shweta
Publicado: (2014)

Handgrip strength evaluation in CKD: do we have enough evidence?
por: Leal, Viviane O., et al.
Publicado: (2020)

Patterns of Opioid Use Among Patients With Inflammatory Bowel Disease: Do We Need Better Disease Control or Multidisciplinary Interventions?
por: Barnes, Edward L
Publicado: (2020)

Why Do Irritable Bowel Syndrome Women Often Have Nausea Symptom?
por: Chang, Full-Young
Publicado: (2012)

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017)

We Should Have Concerns about Risk Transfer
por: Park, Jungsun
Publicado: (2013)

Avoiding food avoidance in patients with inflammatory bowel disease
por: Godny, Lihi, et al.
Publicado: (2023)

Results of the first survey for the current status of inflammatory bowel disease management in Asian countries
por: Kim, Ji Won
Publicado: (2016)

Sex Differences in Science: Do We Have a Problem?
por: van Rooij, Eva, et al.
Publicado: (2019)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
por: Vögelin, Marius, et al.
Publicado: (2016)

We should avoid the term “fluid overload”
por: Vincent, Jean-Louis, et al.
Publicado: (2018)

It's only infection prevention, but infection prevention is all we have
por: Hegde, Ashit V.
Publicado: (2015)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective
por: Ali, Raja Affendi Raja
Publicado: (2015)

Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?
por: Hwang, Sung Wook
Publicado: (2022)

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries
por: Baek, Ji Eun, et al.
Publicado: (2023)

Do Women Have Better Hearing Than Men?
por: Park, Yong-Ho
Publicado: (2021)

The importance of immunization in immune-mediated inflammatory disease cannot be overstated
por: Park, Sang Hyoung
Publicado: (2018)

Sexual rehabilitation or penile rehabilitation – do we have an optimal post-prostatectomy regimen?
por: Skrodzka, Marta
Publicado: (2015)

Do We Have the Right to Challenge the Rules of Nature Using Science and Technology Tools?
por: Sadeghi, Mohammad Reza
Publicado: (2019)

EUS-guided versus percutaneous liver biopsy: Do we have a winner?
por: Diehl, David L, et al.
Publicado: (2022)

Male fertility and semen quality are decreasing – Do we have the expertise to deal with this challenge?
por: Perheentupa, Antti, et al.
Publicado: (2023)

Avoidance and Inhibition Do Not Predict Nonrespondent Bias Among Patients With Inflammatory Bowel Disease
por: Cámara, Rafael J. A., et al.
Publicado: (2011)

TiO(2) – do we have to worry about it? One of the important aetiological factors in inflammatory bowel disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2021)

We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020)

How do we avoid disaster when exiting the European Medicines Agency? Making the most of Brexit in pharmaceutical regulation
por: Hatswell, Anthony James
Publicado: (2017)

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
por: Hasenoehrl, Carina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_moesmilr8esj3a8rp5uivcbjs8